The Blue Cross Blue Shield Association, along with its 28 member health plans, have reportedly racked up at least 27 antitrust lawsuits against the entities. The lawsuits claim a conspiracy among the BCBS conglomerate to break-up the US healthcare market geographically to avoid competing with each other. Reports say the plaintiffs argue the licensing agreements that the insurer has with member plans is anticompetitive and a violation of the Sherman Act, among other antitrust laws; they are seeking to prevent the competition restriction in certain states, as well as three times their actual damages. BCBS held a legal status conference last Thursday concerning the cases.
Featured News
Age-Restriction Laws Are Proliferating; So Too Are the Difficult Tradeoffs Policymakers Face
Dec 23, 2025 by
CPI
Federal AI Strategy Raises Compliance Stakes for Banks and Big Tech
Dec 23, 2025 by
CPI
Google Sues Alleged China-Based Hackers Over Widespread Phishing Scheme
Dec 22, 2025 by
CPI
Europe Moves to Clarify What Counts as Personal Data
Dec 22, 2025 by
CPI
Larry Ellison Offers $40 Billion Guarantee as Paramount Renews Bid for Warner Bros
Dec 22, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi